Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 2/20 | 0.53 |
| ▸ | PLA2G5 | P39877 | 2/20 | 0.53 |
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.44 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.42 |
| ▸ | LAP3 | P28838 | 3/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3702684 | 1.00 | PLA2G2A (0.53) | PLA2G2APLA2G5BCHEALDH1A1MEN1 | |
| SCHEMBL8230655 | 0.94 | PLA2G2A (0.55) | PLA2G2APLA2G5BCHEALDH1A1MEN1 | |
| SCHEMBL8495401 | 0.94 | PLA2G2A (0.55) | PLA2G2APLA2G5BCHEALDH1A1MEN1 | |
| SCHEMBL8674366 | 0.93 | PLA2G2A (0.58) | PLA2G2APLA2G5BCHEALDH1A1MEN1 | |
| SCHEMBL13279091 | 0.93 | PLA2G2A (0.58) | PLA2G2APLA2G5BCHEALDH1A1MEN1 | |
| SCHEMBL25335826 | 0.93 | PLA2G2A (0.58) | PLA2G2APLA2G5BCHEALDH1A1MEN1 | |
| SCHEMBL5171168 | 0.93 | PLA2G2A (0.58) | PLA2G2APLA2G5BCHEALDH1A1MEN1 | |
| SCHEMBL25335737 | 0.93 | PLA2G2A (0.58) | PLA2G2APLA2G5BCHEALDH1A1MEN1 | |
| SCHEMBL8674369 | 0.93 | PLA2G2A (0.58) | PLA2G2APLA2G5BCHEALDH1A1MEN1 | |
| SCHEMBL13279088 | 0.93 | PLA2G2A (0.58) | PLA2G2APLA2G5BCHEALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101601634-B | Infant anus skin care solution | ZHANG JIEYU | 2012-07-18 | — | — | CN | claimed |
| CN-101601634-A | Infant anus skin care solution | YULIN ZHANG (CN) | 2009-12-16 | — | — | CN | claimed |
| EP-3647319-B1 | PEPTIDE COMPOUND, APPLICATION THEREOF AND COMPOSITION CONTAINING SAME | XDCEXPLORER SHANGHAI CO LTD (CN) | 2025-04-09 | — | — | EP | disclosed |
| US-12129312-B2 | Peptide compound, application thereof and composition containing same | XDCEXPLORER (SHANGHAI) CO., LTD. (CN) | 2024-10-29 | — | — | US | disclosed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| US-20240209023-A1 | PEPTIDE COMPOUND, APPLICATION THEREOF AND COMPOSITION CONTAINING SAME | XDCEXPLORER (SHANGHAI) CO., LTD. (CN) | 2024-06-27 | — | — | US | disclosed |
| US-20210403506-A1 | PEPTIDE COMPOUND, APPLICATION THEREOF AND COMPOSITION CONTAINING SAME | XDCEXPLORER (SHANGHAI) CO., LTD. (CN) | 2021-12-30 | — | — | US | disclosed |
| EP-3647319-A1 | PEPTIDE COMPOUND, APPLICATION THEREOF AND COMPOSITION CONTAINING SAME | XDCExplorer (Shanghai) Co., Ltd. (CN) | 2020-05-06 | — | — | EP | disclosed |
| EP-3197891-A1 | FACTOR XIA-INHIBITING PYRIDOBENZAZEPINE AND PYRIDOBENZAZOCINE DERIVATIVES | Bayer Pharma Aktiengesellschaft (DE) | 2017-08-02 | — | — | EP | disclosed |
| WO-2016046157-A1 | FACTOR XIA-INHIBITING PYRIDOBENZAZEPINE AND PYRIDOBENZAZOCINE DERIVATIVES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2016-03-31 | — | — | WO | disclosed |
| CN-102112486-B | Hepatitis c virus inhibitors | BRISTOL MYERS SQUIBB CO | 2014-02-12 | — | — | CN | disclosed |
| CN-101601634-A | Infant anus skin care solution | YULIN ZHANG (CN) | 2009-12-16 | — | — | CN | disclosed |
| CN-101296910-A | Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase | METHYLGENE INC (CA) | 2008-10-29 | — | — | CN | disclosed |
| EP-1940805-A1 | BENZODIAZEPINE AND BENZOPIPERAZINE ANALOG INHIBITORS OF HISTONE DEACETYLASE | Methylgene, Inc. (CA) | 2008-07-09 | — | — | EP | disclosed |
| CN-101165056-A | Optical activity alpha-amino acid and preparation of derivative thereof | WUHAN ENDEHUA TECHNOLOGY CO LT (CN) | 2008-04-23 | — | — | CN | disclosed |
| WO-2007022638-A1 | BENZODIAZEPINE AND BENZOPIPERAZINE ANALOG INHIBITORS OF HISTONE DEACETYLASE | METHYLGENE INC. (CA) | 2007-03-01 | — | — | WO | disclosed |
| CN-1171118-A | Fibronectin adhesion inhibitors | ZENECA LTD (GB) | 1998-01-21 | — | — | CN | disclosed |
| CN-1085546-A | Aminediol protease inhibitors | SQUIBB & SONS INC (US) | 1994-04-20 | — | — | CN | disclosed |
| CN-1085223-A | The 17-beta substitution-4-azepine-5 α-androstane-3-one derivative | ERBA CARLO SPA (IT) | 1994-04-13 | — | — | CN | disclosed |
| US-4069385-A | FROM AN OLEFIN AND AN ORGANIC PEROXIDE WITH COPPER-SCHIFF BASE COMPEX AS CATALYST | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1978-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12129312-B2 | Peptide compound, application thereof and composition containing same | VIP, NGLY1, FURIN | PLA2G2A 4051/4885PLA2G5 2807/4885BCHE 294/4885 |
| US-20210403506-A1 | PEPTIDE COMPOUND, APPLICATION THEREOF AND COMPOSITION CONTAINING SAME | VIP, NGLY1, PEPD | PLA2G2A 4575/4885PLA2G5 2521/4885BCHE 993/4885 |
| US-20240209023-A1 | PEPTIDE COMPOUND, APPLICATION THEREOF AND COMPOSITION CONTAINING SAME | VIP, NGLY1, FURIN | PLA2G2A 3880/4885PLA2G5 2745/4885BCHE 271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.